• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants.

作者信息

Abbasi Jennifer

出版信息

JAMA. 2021 May 25;325(20):2033-2035. doi: 10.1001/jama.2021.7212.

DOI:10.1001/jama.2021.7212
PMID:33950236
Abstract
摘要

相似文献

1
Researchers Tie Severe Immunosuppression to Chronic COVID-19 and Virus Variants.研究人员将严重免疫抑制与慢性新冠病毒感染及病毒变体联系起来。
JAMA. 2021 May 25;325(20):2033-2035. doi: 10.1001/jama.2021.7212.
2
Treatment of chronic COVID-19 with convalescent/postvaccination plasma in patients with hematologic malignancies.在血液系统恶性肿瘤患者中使用恢复期/疫苗接种后血浆治疗慢性 COVID-19。
Int J Cancer. 2024 Aug 15;155(4):618-626. doi: 10.1002/ijc.34988. Epub 2024 May 9.
3
Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infection.两名免疫功能低下的持续性 COVID-19 感染者在抗体治疗后出现刺突突变的演变。
J Med Virol. 2022 Mar;94(3):1241-1245. doi: 10.1002/jmv.27445. Epub 2021 Nov 13.
4
SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.严重急性呼吸综合征冠状病毒2变体与康复期血浆：现实、谬误与机遇
J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI148832.
5
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.病例报告：双滤过血浆置换获得的抗 SARS-CoV-2 恢复期抗体的作用。
Front Immunol. 2021 Jun 30;12:711915. doi: 10.3389/fimmu.2021.711915. eCollection 2021.
6
COVID-19 pneumonia, immunosuppression, and cytomegalovirus activation: A perspective.新型冠状病毒肺炎、免疫抑制与巨细胞病毒激活：一种观点。
J Postgrad Med. 2021 Apr-Jun;67(2):65-66. doi: 10.4103/jpgm.JPGM_55_21.
7
Fast-spreading COVID variant can elude immune responses.快速传播的新冠病毒变种能够逃避免疫反应。
Nature. 2021 Jan;589(7843):500-501. doi: 10.1038/d41586-021-00121-z.
8
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.免疫功能低下宿主接受恢复期血浆治疗后出现多种 SARS-CoV-2 抗体逃逸变异体。
mSphere. 2021 Aug 25;6(4):e0048021. doi: 10.1128/mSphere.00480-21.
9
COVID-19 Early After a Deceased Donor Kidney Transplant Surgery.已故供体肾移植术后早期的新型冠状病毒肺炎
Transplantation. 2020 Dec;104(12):e354-e355. doi: 10.1097/TP.0000000000003439.
10
Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients.关于使用新冠康复者血浆治疗免疫功能低下患者的建议。
Semin Thromb Hemost. 2024 Jun;50(4):648-653. doi: 10.1055/s-0043-1776876. Epub 2023 Nov 20.

引用本文的文献

1
Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants.霉酚酸治疗促使新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体出现。
Proc Natl Acad Sci U S A. 2025 Jul 15;122(28):e2500276122. doi: 10.1073/pnas.2500276122. Epub 2025 Jul 9.
2
Evaluating the Impact of Age and Comorbidities on COVID-19 Outcomes and Healthcare Costs: A Comparative Analysis of Immunocompromised and General Populations in the United States (EON-US).评估年龄和合并症对新冠病毒疾病结局及医疗成本的影响：美国免疫功能低下人群与普通人群的比较分析（EON-US）
Infect Dis Ther. 2025 Jun;14(6):1343-1367. doi: 10.1007/s40121-025-01160-z. Epub 2025 Jun 4.
3
Exploring genetic loci linked to COVID-19 severity and immune response through multi-trait GWAS analyses.
通过多性状全基因组关联研究分析探索与新冠病毒疾病严重程度和免疫反应相关的基因位点。
Front Genet. 2025 Feb 17;16:1502839. doi: 10.3389/fgene.2025.1502839. eCollection 2025.
4
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial.在患有轻度新型冠状病毒肺炎（COVID-19）的临床易感个体中进行早期、高滴度恢复期血浆治疗：一项国际随机开放标签试验
EBioMedicine. 2025 Mar;113:105613. doi: 10.1016/j.ebiom.2025.105613. Epub 2025 Feb 27.
5
Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.免疫功能低下宿主持续性 SARS-CoV-2 感染的晚期抗病毒治疗效果。
J Virol. 2024 Sep 17;98(9):e0090524. doi: 10.1128/jvi.00905-24. Epub 2024 Aug 29.
6
Immune aging: biological mechanisms, clinical symptoms, and management in lung transplant recipients.免疫衰老：肺移植受者的生物学机制、临床症状及管理
Front Transplant. 2024 Feb 8;3:1356948. doi: 10.3389/frtra.2024.1356948. eCollection 2024.
7
In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockade.通过阻断人血管紧张素转换酶 2（ACE2）受体抑制体外 SARS-CoV-2 抗体介导的感染。
Immunol Lett. 2024 Aug;268:106887. doi: 10.1016/j.imlet.2024.106887. Epub 2024 Jun 24.
8
Decoding Immuno-Competence: A Novel Analysis of Complete Blood Cell Count Data in COVID-19 Outcomes.解码免疫能力：对新冠病毒疾病结局中全血细胞计数数据的新分析
Biomedicines. 2024 Apr 15;12(4):871. doi: 10.3390/biomedicines12040871.
9
Assessing the Burden and Cost of COVID-19 Across Variants in Commercially Insured Immunocompromised Populations in the United States: Updated Results and Trends from the Ongoing EPOCH-US Study.评估美国商业保险免疫功能低下人群中不同变异株 COVID-19 的负担和成本：正在进行的 EPOCH-US 研究的最新结果和趋势。
Adv Ther. 2024 Mar;41(3):1075-1102. doi: 10.1007/s12325-023-02754-0. Epub 2024 Jan 13.
10
Clinical Evaluation of Direct Reverse Transcription PCR for Detection of SARS-CoV-2 Compared to Conventional RT-PCR in Patients with Positive Rapid Antigen Test Results during Circulation of Emerging Viral Variants.在新型病毒变体传播期间，对快速抗原检测结果呈阳性的患者，直接逆转录PCR检测新型冠状病毒2与传统逆转录PCR的临床评估。
Diagnostics (Basel). 2023 Dec 14;13(24):3668. doi: 10.3390/diagnostics13243668.